Citations

Mayo Clinic

Showing 10 of 108599 citations.

An ex vivo chemoresponse assay predicts carboplatin-induced progression-free interval in ovarian cancer
Coleman, Rob, Herzog, Thomas J. , Hosford, S., Sevin, Bernd‐Uwe, Fiori, L., Gallion, Holly H., Wells, Alan

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 5134-5134

10.1200/jco.2004.22.90140.5134 Get It

Ex vivo chemoresponse assay of ovarian cancers predicts clinical outcome
Gallion, Holly H., Wa, Christopherson, Coleman, Rob, Herzog, Thomas J. , Sevin, Bernd‐Uwe, Fiori, L., Wells, Alan

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 5074-5074

10.1200/jco.2004.22.90140.5074 Get It

Heterogeneity in chemoresponsiveness of ovarian cancer as demonstrated by an ex vivo chemo response assay
Ochs, Robert, Gallion, Holly H., Coleman, Rob, Herzog, Thomas J. , Sevin, B.U., Schellhas, Helmut F., Wells, Alan

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 5059-5059

10.1200/jco.2004.22.90140.5059 Get It

Preliminary evidence of relationship between genetic markers and oncology patient quality of life (QOL)
Sloan, Jeffrey A., McLeod, H. L., Zhao, Xingping , Ramanathan, Ramesh K., Findlay, B., Morton, Roscoe F., Goldberg, Richard M. , Sargent, Daniel J. , Zhao, X., Fuchs, C., Williamson, Stephen K.

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 5-5

10.1200/jco.2004.22.90140.5 Get It

Radiofrequency ablation as an alternative treatment for renal carcinoma in the elderly
Tan, Winston , Fumagalli, Ricardo Paz

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 4709-4709

10.1200/jco.2004.22.90140.4709 Get It

Quality of life (QOL) and pain in advanced stage prostate cancer: impact of missing data on evaluating palliation in SWOG 9916
Moinpour, Carol M. , Vinson, Liara, Lara, Primo N. , Taplin, Mary‐Ellen , Burch, Patrick, Petrylak, Daniel P. , Berry, Donna Lynn , Jiang, Chen , Lanier, Stephen M. , Crawford, Emily D.

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 4579-4579

10.1200/jco.2004.22.90140.4579 Get It

Low dose interferon-α2b (IFN) + thalidomide (T) in patients (pts) with previously untreated renal cell cancer (RCC). Improvement in progression-free survival (PFS) but not quality of life (QoL) or overall survival (OS). A phase III study of the Eastern Coo
Manola, Judith , Fairclough, Diane L., Cella, David , Richardson, Ronald L., Sosman, Jeffrey A. , Kasimis, Basil, Wilding, George, Gordon, Michael Solomon , Dutcher, Janice P.

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 4516-4516

10.1200/jco.2004.22.90140.4516 Get It

Three-month change in PSA as a surrogate endpoint for mortality in advanced hormone-refractory prostate cancer (HRPC): Data from Southwest Oncology Group Study S9916
Pauler, Donna K., Taplin, Mary Ellen, Burch, Patrick A. , Greene, Graham, Lara, Primo N. , Petrylak, Daniel P. , Crawford, Emily D. , Tangen, Catherine M. , Hussain, Maha , Small, Eric J. , Greene, G. F.

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 4505-4505

10.1200/jco.2004.22.90140.4505 Get It

Small molecule Bcl-2 inhibitor enhances apoptosis induction by gemcitabine or sulindac sulfide in BxPC-3 pancreatic cancer cells
Freeburg, E. N., Sinicrope, Frank A.

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 4256-4256

10.1200/jco.2004.22.90140.4256 Get It

Gemcitabine (Gem), cisplatin (Cis) and radiation therapy (RT) for patients with locally advanced pancreatic adenocarcinoma (ACA): A North Central Cancer Treatment Group (NCCTG) phase II study
Haddock, Michael G. , Swaminathan, Rajaraman , Hauge, Mark D., Foster, Nathan R. , Martenson, James A., Goldberg, R. M. , Alberts, Steven R.

Journal of Clinical Oncology | April 5, 2017 | Volume: 22 | Issue: 14_suppl | Pages: 4121-4121

10.1200/jco.2004.22.90140.4121 Get It